Insys Therapeutics Inc., grappling with the prospect of bankruptcy after its founder was convicted on racketeering charges, agreed to pay $225 million to.
Insys Therapeutics Inc., grappling with the prospect of bankruptcy after its founder was convicted on racketeering charges, agreed to pay $225 million to.
NEW YORK , June 6, 2019 /PRNewswire/ -- This report provides a forecast analysis of the global plastic jar packaging market. It provides historical data of ...
MIAMI, Okla. — The U.S. Environmental Protection Agency will begin working this week to remove asbestos-tainted debris piles from the former B.F. Goodrich ...
A Hummels Wharf car dealership is being sued by its parent company who is seeking to recover more than $600000 in owed payments and credits involving the ...
A Delaware bankruptcy judge approved a settlement Wednesday between life insurance investment firm White Eagle Asset Portfolio LP and its secured lender ...
Music trade bodies and charities from across the U.K. have joined forces to access the impact of PledgeMusic's collapse and support the large number of British ...
Insys Therapeutics Inc., grappling with the prospect of bankruptcy after its founder was convicted on racketeering charges, agreed to pay $225 million to settle ...